Company intelligence / Profile preview
Theramex
- Ownership
- Private
- Development stage
- Commercial
Overview
Theramex has established itself as a global leader in women’s health pharmaceuticals with commercial products addressing contraception, menopause, osteoporosis, fertility. The company has expanded its portfolio through acquisitions and new product launches. It focuses on patient-centric solutions supporting women at all life stages. Recent growth driven by operational transformation post-acquisition by private equity firms.
- Therapeutic areas
- Women's HealthEndocrinology
- Modalities
- Pharmaceuticals for women’s health including hormonal therapies and other specialty medicines related to contraception, fertility, menopause, osteoporosis.
- Industry
- Biotech
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on Theramex.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Theramex.